⌘K

Login Start Free

Home/Filings/4/0001209191-15-015568

4//SEC Filing

KALOBIOS PHARMACEUTICALS INC 4

Accession 0001209191-15-015568

CIK 0001293310operating

View on SEC.gov Company Profile

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 6:36 PM ET

Size

5.4 KB

Accession

0001209191-15-015568

Insider Transaction Report

Form 4

Period: 2015-02-16

KALOBIOS PHARMACEUTICALS INCKBIO

Yarranton Geoffrey Thomas

Chief Scientific Officer

Transactions

Award
Stock Options (right to buy)
2015-02-16+300,000→ 300,000 total
Exercise: $0.45Exp: 2025-02-15→ Common Stock (300,000 underlying)

Footnotes (1)

[F1]1/4 of the option shares will vest and become exercisable on each 6-month anniversary of continuous service after February 16, 2015.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

KALOBIOS PHARMACEUTICALS INC

CIK 0001293310

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001293310

Filing Metadata

Form type: 4
Filed: Feb 17, 7:00 PM ET
Accepted: Feb 18, 6:36 PM ET
Size: 5.4 KB

View on SEC.gov